Showing results (1-10 of 351) with videos related to

Sort By:
Pageof 36
Expert Review of Cardiovascular Therapy|March 13, 2010
Benefits of and safety concerns associated with drug-eluting coronary stentsScot Garg, Patrick Serruys
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)Victor M Legrand, Scot Garg, Patrick W Serruys, et al.
The American Journal of Cardiology|May 3, 2011
Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stentsGiovanna Sarno, Lorenz Räber, Yoshinobu Onuma, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 8, 2025
Serial quantitative optical coherence tomography for luminal volume changes following either paclitaxel or sirolimus coated balloon in de novo small coronary artery lesionsAkihiro Tobe, Patrick Serruys, Kotaro Miyashita, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Meditations on secondary revascularisation in the aftermath of the SYNTAX trialScot Garg, Patrick W Serruys
Current Treatment Options in Cardiovascular Medicine|November 30, 2012
An update on drug-eluting stentsScot Garg, Patrick W Serruys
Journal of the American College of Cardiology|August 28, 2010
Coronary stents: looking forwardScot Garg, Patrick W Serruys
Nature Reviews. Cardiology|April 9, 2009
Coronary angioplasty: do we need to EuroSCORE?Scot Garg, Patrick W Serruys
Journal of the American College of Cardiology|August 28, 2010
Coronary stents: current statusScot Garg, Patrick W Serruys
JACC. Cardiovascular Interventions|February 5, 2010
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions)Scot Garg, Patrick Serruys, Yoshinobu Onuma, et al.
Pageof 36